Old Web
English
Sign In
Acemap
>
authorDetail
>
Zhijian Tang
Zhijian Tang
Peking University
Ovarian cancer
Medicine
Internal medicine
Pathology
Biomarker (medicine)
5
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer.
2021
Frontiers in Immunology
Hongyan Cheng
Ruiqiong Ma
Shang Wang
Yu Wang
Ying-Chun Li
Zhijian Tang
Sha Dou
Yuanfen Wang
Hong-Lan Zhu
Xue Ye
Tianyu Zhang
Yong-Hua Zhang
Shufen Li
Yong Hong Zhao
Yi Li
Heng Cui
Xiaohong Chang
Show All
Source
Cite
Save
Citations (0)
Age and menopausal status are important factors influencing the serum human epididymis secretory protein 4 level: a prospective cross-sectional study in healthy Chinese people.
2020
Chinese Medical Journal
Hongyan Cheng
Lin Zeng
Xue Ye
Ruiqiong Ma
Zhijian Tang
Hongling Chu
Yiming Zhao
Li-rong Zhu
Yu-Nong Gao
Xiaohong Chang
Heng Cui
Show All
Source
Cite
Save
Citations (4)
Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival
2018
Pathology Research and Practice
Ruiqiong Ma
Zhijian Tang
Kunkun Sun
Xue Ye
Hongyan Cheng
Xiaohong Chang
Heng Cui
Show All
Source
Cite
Save
Citations (7)
Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer
2018
Archives of Gynecology and Obstetrics
Ruiqiong Ma
Zhijian Tang
Xue Ye
Hongyan Cheng
Kunkun Sun
Xiaohong Chang
Heng Cui
Show All
Source
Cite
Save
Citations (2)
Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma
2015
Chinese Journal of Cancer Research
Zhijian Tang
Xiaohong Chang
Xue Ye
Yi Li
Hongyan Cheng
Heng Cui
Show All
Source
Cite
Save
Citations (11)
1